Related references
Note: Only part of the references are listed.Overexpression of Heparanase Lowers the Amyloid Burden in Amyloid-β Precursor Protein Transgenic Mice
Charlotte B. Jendresen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
beta-Amyloid Is Transmitted via Neuronal Connections along Axonal Membranes
Ha-Lim Song et al.
ANNALS OF NEUROLOGY (2014)
Deficiency in LRP6-Mediated Wnt Signaling Contributes to Synaptic Abnormalities and Amyloid Pathology in Alzheimer's Disease
Chia-Chen Liu et al.
NEURON (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients
Joel C. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
Jing L. Guo et al.
CELL (2013)
Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products
Fang Cheng et al.
GLYCOBIOLOGY (2013)
Neuronal Clearance of Amyloid-β by Endocytic Receptor LRP1
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Mass Spectrometric Approach for Characterization of Amyloid-β Aggregates and Identification of Their Post-Translational Modifications
William M. Tay et al.
BIOCHEMISTRY (2012)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms
Jie Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology
Pritam Das et al.
MOLECULAR NEURODEGENERATION (2012)
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
Katherine L. Youmans et al.
MOLECULAR NEURODEGENERATION (2012)
Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate
Fumitoshi Irie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Neurovascular Dysfunction and Faulty Amyloid β-Peptide Clearance in Alzheimer Disease
Abhay P. Sagare et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Proteolytic Degradation of Amyloid β-Protein
Takaomi Saido et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Changes in Brain β-Amyloid Deposition and Aquaporin 4 Levels in Response to Altered Agrin Expression in Mice
Steven M. Rauch et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Heparan Sulphate Proteoglycan and the Low-Density Lipoprotein Receptor-Related Protein 1 Constitute Major Pathways for Neuronal Amyloid-β Uptake
Takahisa Kanekiyo et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations
Katherine Lynn Youmans et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
John R. Cirrito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Heparan Sulfate Proteoglycans
Stephane Sarrazin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
Elina Sandwall et al.
GLYCOBIOLOGY (2010)
IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice
Paramita Chakrabarty et al.
JOURNAL OF IMMUNOLOGY (2010)
Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease
N. M. Timmer et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer Disease
Weiming Xia et al.
ARCHIVES OF NEUROLOGY (2009)
Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain
Karrie E. Grear et al.
MOLECULAR NEURODEGENERATION (2009)
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Guojun Bu
NATURE REVIEWS NEUROSCIENCE (2009)
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
Xiaoyan Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Dennis J. Selkoe
BEHAVIOURAL BRAIN RESEARCH (2008)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease
Roy O. Weller et al.
BRAIN PATHOLOGY (2008)
Amyloid-β(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfatet
Vijayaraghavan Rangachari et al.
BIOCHEMISTRY (2007)
Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy
Wesley Farris et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host
Melanie Meyer-Luehmann et al.
SCIENCE (2006)
Characterization of the Drosophila melanogaster genome at the nuclear lamina
Helen Pickersgill et al.
NATURE GENETICS (2006)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Two-step mechanism of binding of apolipoprotein E to heparin
M Futamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease
L Bergamaschini et al.
JOURNAL OF NEUROSCIENCE (2004)
Glypican-1 as an Aβ binding HSPG in the human brain:: Its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease
N Watanabe et al.
FASEB JOURNAL (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Mammalian brain morphogenesis and midline axon guidance require heparan sulfate
M Inatani et al.
SCIENCE (2003)
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders
J van Horssen et al.
LANCET NEUROLOGY (2003)
γ-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
WT Kimberly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease
DJ Selkoe
JOURNAL OF CLINICAL INVESTIGATION (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro
L Bergamaschini et al.
NEUROBIOLOGY OF AGING (2002)
Heparan sulfate: decoding a dynamic multifunctional cell regulator
J Turnbull et al.
TRENDS IN CELL BIOLOGY (2001)
Cell surface heparan sulfate proteoglycans: Selective regulators of ligand-receptor encounters
PW Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice
X Lin et al.
DEVELOPMENTAL BIOLOGY (2000)
Agrin binds to β-amyloid (Aβ), accelerates Aβ fibril formation, and is localized to AB deposits in Alzheimer's disease brain
SL Cotman et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Share Paper
